共 50 条
Source of angiopoietin-2 in the sera of women during pregnancy
被引:11
|作者:
Woolnough, C.
[1
]
Wang, Y.
[1
]
Kan, C. Y.
[1
]
Morris, J. M.
[1
]
Tasevski, V.
[1
,2
,3
]
Ashton, A. W.
[1
]
机构:
[1] Univ Sydney, Div Perinatal Res, Kolling Inst Med Res, Royal N Shore Hosp, St Leonards, NSW 2065, Australia
[2] Pacific Lab Med Serv, St Leonards, NSW, Australia
[3] Univ Technol Sydney, Dept Cell & Mol Biol, Sydney, NSW 2007, Australia
基金:
英国医学研究理事会;
关键词:
ENDOTHELIAL GROWTH-FACTOR;
IN-VITRO;
CELL SURVIVAL;
TIE2;
RECEPTOR;
EXPRESSION;
ANGIOGENESIS;
VESSELS;
LIGAND;
CYTOTROPHOBLASTS;
STIMULATION;
D O I:
10.1016/j.mvr.2012.08.003
中图分类号:
R6 [外科学];
学科分类号:
1002 ;
100210 ;
摘要:
Placental development requires coordinated angiogenesis regulated by multiple factors including angiopoietins. Previously we demonstrated that the concentration of angiopoietin-2 (Ang-2) in the sera of women rises markedly in pregnancy in early gestation. This increase is reduced in pregnancies subsequently complicated by intrauterine growth restriction (IUGR). We now show that the concentration of Ang-2, but not Ang-1, in maternal serum is increased during normal pregnancy, peaking at the end of the first trimester. We also demonstrate that a key source of the elevated Ang-2 levels during pregnancy is decidual endothelial cells (DECs) but not cytotrophoblasts. Secretion of Ang-2 by DECs relies on the release from intracellular stores and the synthesis of new Ang-2 protein and is regulated by serum factors at a translational level. Further studies on the role of Ang-2 during pregnancy are warranted as well as the evaluation of Ang-2 as a marker to predict adverse pregnancy outcomes. Crown Copyright (C) 2012 Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:367 / 374
页数:8
相关论文